SOA Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
SOA Wealth Advisors's AZN Position: Q2 2026 in Review
SOA Wealth Advisors opened a new position in AstraZeneca (AZN) in Q2 2026: 21,280 shares worth $42.8K. The stake represents 0.01% of the portfolio and ranks #420 among its holdings. This is a return to the name: SOA Wealth Advisors previously reported a position in AZN as recently as Q4 2025.
SOA Wealth Advisors first reported a position in AZN in Q4 2020 and has held it in 22 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- SOA Wealth Advisors held 21,280 shares of AstraZeneca worth $42.8K as of Q2 2026.
- AstraZeneca was a new SOA Wealth Advisors position in Q2 2026.
- AstraZeneca made up 0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #420 holding.
- SOA Wealth Advisors first reported a position in AstraZeneca in Q4 2020 and has held it in 22 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.